Shen Lian Biomedical: UBI plans to reduce its holdings by no more than 3% of shares
I'm PortAI, I can summarize articles.
Shen Lian Biomedical announced that United BioPharma, Inc. (UBI) plans to reduce its holdings by no more than 3% within the next three months to raise funds for the clinical trials and commercialization of an Alzheimer's vaccine. The specific reduction methods include reducing 4.1064 million shares through centralized bidding and reducing 8.2129 million shares through block trading
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments